How We Do Bioequivalen Study in Our Land

Writer and Editor : dr. Natalia Dendawijaya

Depok, Mei 2025 - Biometrik Riset Indonesia is a company engaged in pharmaceutical research, specifically in the field of bioequivalence studies. These studies aim to compare the efficacy and safety of a test drug with a reference (patented) drug through a series of phases, including screening, study, and sample analysis.

(The briefing process by responsible physician)

The screening phase involves the selection process of potential research subjects, which begins with a briefing session, registration, signing of informed consent, and health examinations. The health examinations include physical check-ups by a physician, electrocardiograms (ECG), as well as blood and urine tests.

Subjects who pass the screening phase and meet the eligibility criteria will proceed to the study phase. In this stage, participants undergo several procedures such as blood sample collection, adverse event monitoring, and regular blood pressure monitoring.

(The study process and the sample separation room)

The final phase is the sample analysis, in which the collected blood samples are analyzed to assess the level of biological equivalence (bioequivalence) between the test drug and the reference drug. The results of this analysis serve as the basis for determining whether the test drug demonstrates comparable efficacy and safety to the reference drug.